|
1
|
Matthews NH, Li WQ, Qureshi AA, Weinstock
MA and Cho E: Epidemiology of melanoma. Environmental and molecular
mutagenesis. 2017.
|
|
2
|
Goel N, Ward WH, Yu JQ and Farma JM:
Short-term and long-term management of melanoma. Cutaneous
melanoma: Etiology and therapy. Ward WH and Farma JM: Codon
Publications; Brisbane (AU): 2017, View Article : Google Scholar
|
|
3
|
Joyce KM: Surgical management of melanoma.
Cutaneous Melanoma: Etiology and therapy. Ward WH and Farma JM:
Codon Publications; Brisbane (AU): 2017, View Article : Google Scholar
|
|
4
|
Norval M and Wright CY: The Epidemiology
of cutaneous melanoma in the white and black African population
groups in South Africa. Cutaneous melanoma: Etiology and therapy.
Ward WH and Farma JM: Codon Publications; Brisbane (AU): 2017,
View Article : Google Scholar
|
|
5
|
Rausch MP and Hastings KT: Immune
checkpoint inhibitors in the treatment of melanoma: From basic
science to clinical application. Cutaneous melanoma: Etiology and
therapy. Ward WH and Farma JM: Codon Publications; Brisbane (AU):
2017, View Article : Google Scholar
|
|
6
|
G Lben K, Berberoglu U, Altinyollar H,
Kinas V and Turanli S: Sentinel lymph node status affects long-term
survival in patients with intermediate-thickness melanoma. J Cancer
Res Ther. 12:840–844. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Phan NN, Wang CY, Li KL, Chen CF, Chiao
CC, Yu HG, Huang PL and Lin YC: Distinct expression of CDCA3,
CDCA5, and CDCA8 leads to shorter relapse free survival in breast
cancer patient. Oncotarget. 9:6977–6992. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gu Y, Lu L, Wu L, Chen H, Zhu W and He Y:
Identification of prognostic genes in kidney renal clear cell
carcinoma by RNAseq data analysis. Mol Med Rep. 15:1661–1667. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yan H, Li Z, Shen Q, Wang Q, Tian J, Jiang
Q and Gao L: Aberrant expression of cell cycle and material
metabolism related genes contributes to hepatocellular carcinoma
occurrence. Pathol Res Pract. 213:316–321. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li S, Liu X, Liu T, Meng X, Yin X, Fang C,
Huang D, Cao Y, Weng H, Zeng X and Wang X: Identification of
biomarkers correlated with the TNM staging and overall survival of
patients with bladder cancer. Front Physiol. 8:9472017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun L, Li J and Yan B: Gene expression
profiling analysis of osteosarcoma cell lines. Mol Med Rep.
12:4266–4272. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiao DC, Lu ZD, Qiao JH, Yan M, Cui SD and
Liu ZZ: Expression of CDCA8 correlates closely with FOXM1 in breast
cancer: Public microarray data analysis and immunohistochemical
study. Neoplasma. 62:464–469. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Çarçak N, Yavuz M, Eryiğit Karamahmutoğlu
T, Kurt AH, Urhan Küçük M, Onat FY and Büyükafsar K: Suppressive
effect of Rho-kinase inhibitors Y-27632 and fasudil on
spike-and-wave discharges in genetic absence epilepsy rats from
Strasbourg (GAERS). Naunyn-Schmiedebergs Arch Pharmacol.
391:1275–1283. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cho SY, Sung CO, Chae J, Lee J, Na D, Kang
W, Kang J, Min S, Lee A, Kwak E, et al: Alterations in the Rho
pathway contribute to Epstein-Barr virus-induced lymphomagenesis in
immunosup-pressed environments. Blood. 131:1931–1941. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dos Santos AA, López-Granero C, Farina M,
Rocha JBT, Bowman AB and Aschner M: Oxidative stress, caspase-3
activation and cleavage of ROCK-1 play an essential role in
MeHg-induced cell death in primary astroglial cells. Food Chem
Toxicol. 113:328–336. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Honjo M and Tanihara H: Impact of the
clinical use of ROCK inhibitor on the pathogenesis and treatment of
glaucoma. Jap J Ophthalmol. 62:109–126. 2018. View Article : Google Scholar
|
|
17
|
Li N, Chen J, Zhao J and Wang T:
MicroRNA-3188 targets ETS-domain protein 4 and participates in
RhoA/ROCK pathway to regulate the development of atherosclerosis.
Pharmazie. 72:687–693. 2017.
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Dai C, Miao CX, Xu XM, Liu LJ, Gu YF, Zhou
D, Chen LS, Lin G and Lu GX: Transcriptional activation of human
CDCA8 gene regulated by transcription factor NF-Y in embryonic stem
cells and cancer cells. J Biol Chem. 290:22423–22434. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Papini D, Langemeyer L, Abad MA, Kerr A,
Samejima I, Eyers PA, Jeyaprakash AA, Higgins JM, Barr FA and
Earnshaw WC: TD-60 links RalA GTPase function to the CPC in
mitosis. Nat Commun. 6:76782015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Marko NF, Weil RJ, Schroeder JL, Lang FF,
Suki D and Sawaya RE: Extent of resection of glioblastoma
revisited: Personalized survival modeling facilitates more accurate
survival prediction and supports a maximum-safe-resection approach
to surgery. J Clin Oncol Mar. 32:774–82. 2014. View Article : Google Scholar
|
|
22
|
Huang SK and Hoon DS: Liquid biopsy
utility for the surveillance of cutaneous malignant melanoma
patients. Mol Oncol. 10:450–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pan Y, Haydon AM, McLean CA, McDonald PB
and Kelly JW: Prognosis associated with cutaneous melanoma
metastases. Australas J Dermatol. 56:25–28. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jaber DF, Jallad MN and Abdelnoor AM: The
effect of ciprofloxacin on the growth of B16F10 melanoma cells. J
Cancer Res Ther. 13:956–960. 2017.PubMed/NCBI
|
|
25
|
Weiss SA, Hanniford D, Hernando E and
Osman I: Revisiting determinants of prognosis in cutanous melanoma.
Cancer. 121:4108–4123. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
McCarthy CG, Wenceslau CF, Ogbi S, Szasz T
and Webb RC: Toll-like receptor 9-dependent AMPKalpha activation
occurs via TAK1 and contributes to RhoA/ROCK signaling and actin
polymerization in vascular smooth muscle cells. J Pharmacol Exp
Ther. 365:60–71. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Takaoka M, Ito S, Miki Y and Nakanishi A:
FKBP51 regulates cell motility and invasion via RhoA signaling.
Cancer Sci. 108:380–389. 2017. View Article : Google Scholar :
|
|
28
|
Pich C, Teiti I, Sarrabayrouse G, Gallardo
F, Gence R and Tilkin-Mariame AF: Melanoma expressed-CD70 is
regulated by RhoA and MAPK pathways without affecting vemurafenib
treatment activity. PLoS One. 11:e01480952016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sahin L, Cevik OS, Koyuncu DD and
Buyukafsar K: Role of rho-kinase (ROCK) in tonic but not phasic
contraction in the frog stomach smooth muscle. Life Sci. 198:46–55.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zeng Y, Xie H, Qiao Y, Wang J, Zhu X, He
G, Li Y, Ren X, Wang F, Liang L and Ding Y: Formin-like2 regulates
Rho/ROCK pathway to promote actin assembly and cell invasion of
colorectal cancer. Cancer Sci. 106:1385–1393. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shen K, Wang Y, Zhang Y, Zhou H, Song Y,
Cao Z, Kou J and Yu B: Cocktail of four active components derived
from Sheng Mai San inhibits hydrogen peroxide-induced PC12 cell
apoptosis linked with the caspase-3/ROCK1/MLC pathway. Rejuvenation
Res. 18:517–527. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Voorneveld PW, Kodach LL, Jacobs RJ, Liv
N, Zonnevylle AC, Hoogenboom JP, Biemond I, Verspaget HW, Hommes
DW, de Rooij K, et al: Loss of SMAD4 alters BMP signaling to
promote colorectal cancer cell metastasis via activation of Rho and
ROCK. Gastroenterology. 147:196–208. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mu D, Zhou G, Li J, Su B and Guo H:
Ursolic acid activates the apoptosis of prostate cancer via
ROCK/PTEN mediated mitochondrial translocation of cofilin-1. Oncol
Lett. 15:3202–3206. 2018.PubMed/NCBI
|
